First UK patient given GSK’s experimental arthritis drug in COVID-19 trial
Drug is being investigated in up to 800 hospitalised patients nationwide
Read More
Tag: otilimab
GSK launches PhIII programme for otilimab in RA
The Phase III clinical programme is the first in RA to include head-to-head comparisons of otilimab with current treatments across all pivotal studies
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
